Dr. Agrawals Eye Hospital Stock Screener | Share Price & Fundamental Analysis
DRAGARWQ
Hospitals
Screen Dr. Agrawals Eye Hospital share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹5279.80
▲
25.70 (0.49%)
Market Cap
₹2,614.54 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
8.18
EPS (TTM)
₹116.28
Dividend Yield
0.11%
Debt to Equity
1.64
52W High
₹6981.35
52W Low
₹3555.55
Operating Margin
31.00%
Profit Margin
14.55%
Revenue (TTM)
₹433.00
EBITDA
₹138.00
Net Income
₹63.00
Total Assets
₹613.00
Total Equity
₹210.00
Dr. Agrawals Eye Hospital Share Price History - Stock Screener Chart
Screen DRAGARWQ historical share price movements with interactive charts. Analyze price trends and patterns.
Dr. Agrawals Eye Hospital Company Profile - Fundamental Screener
Screen Dr. Agrawals Eye Hospital company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DRAGARWQ shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE934C01018
Dr. Agrawals Eye Hospital Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen DRAGARWQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 613 | 496 | 390 | 314 | 155 | 141 | 100 | 81 | 72 | 79 |
| Current Assets | 56 | 60 | 47 | 50 | 44 | 30 | 30 | 23 | 20 | 24 |
| Fixed Assets | 393 | 316 | 260 | 214 | 96 | 94 | 55 | 36 | 33 | 34 |
| Liabilities | ||||||||||
| Total Liabilities | 613 | 496 | 390 | 314 | 155 | 141 | 100 | 81 | 72 | 79 |
| Current Liabilities | 317 | 258 | 222 | 183 | 52 | 45 | 19 | 9 | 16 | 19 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 210 | 157 | 113 | 78 | 55 | 56 | 46 | 35 | 29 | 23 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 205 | 152 | 109 | 74 | 50 | 51 | 41 | 30 | 25 | 19 |
Screen DRAGARWQ income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 433 | 402 | 324 | 270 | 203 | 141 | 179 | 172 | 156 | 150 | 137 | 118 |
| Expenses | 295 | 279 | 228 | 193 | 144 | 109 | 130 | 141 | 130 | 127 | 120 | 104 |
| EBITDA | 138 | 124 | 96 | 77 | 59 | 31 | 49 | 31 | 26 | 23 | 17 | 15 |
| Operating Profit % | 31.00% | 30.00% | 29.00% | 28.00% | 29.00% | 22.00% | 26.00% | 17.00% | 15.00% | 14.00% | 12.00% | 12.00% |
| Depreciation | 42 | 40 | 27 | 20 | 20 | 19 | 21 | 11 | 10 | 9 | 9 | 6 |
| Interest | 15 | 13 | 7 | 7 | 6 | 6 | 8 | 3 | 3 | 3 | 4 | 3 |
| Profit Before Tax | 82 | 71 | 62 | 49 | 32 | 6 | 20 | 17 | 13 | 11 | -1 | 5 |
| Tax | 19 | 16 | 16 | 13 | 8 | 7 | 6 | 6 | 7 | 4 | -1 | 0 |
| Net Profit | 63 | 55 | 46 | 37 | 24 | -1 | 14 | 12 | 7 | 7 | 0 | 6 |
| EPS | 133.90 | 116.28 | 98.64 | 78.55 | 51.28 | -3.06 | 29.11 | 25.35 | 14.42 | 15.61 | 0.08 | 12.12 |
Dr. Agrawals Eye Hospital Cash Flow Screener - Liquidity Fundamentals
Screen DRAGARWQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 95 | 90 | 70 | 57 | 34 | 39 | 25 | 19 | 20 | 17 |
| Investing Activities | -133 | -70 | -71 | -46 | -11 | -17 | -25 | -11 | -8 | -17 |
| Financing Activities | 17 | -14 | 0 | -4 | -8 | -20 | 2 | -8 | -12 | 0 |
| Net Cash Flow | -22 | 6 | -1 | 7 | 15 | 2 | 2 | -1 | 0 | 0 |
Screen DRAGARWQ shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 72.67% | 71.90% | 71.90% | 71.90% | 71.90% | 71.90% | 71.90% | 71.90% |
| FII Holding | 1.74% | 1.50% | 1.33% | 0.84% | 0.83% | 0.65% | 0.64% | 0.00% |
| DII Holding | 2.36% | 2.31% | 1.95% | 1.03% | 0.96% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.17% | 18.95% | 19.25% | 20.44% | 20.51% | 21.77% | 21.74% | 21.84% |
| Other Holding | 5.06% | 5.34% | 5.57% | 5.79% | 5.80% | 5.69% | 5.72% | 6.27% |
| Shareholder Count | 30,528 | 35,976 | 41,704 | 15,115 | 4,510 | 3,808 | 3,572 | 3,423 |
Dr. Agrawals Eye Hospital Dividend Screener - Share Yield Analysis
Screen DRAGARWQ dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹6.00 | 0.11% |
| 2024-March | ₹2.50 | 0.06% |
| 2023-March | ₹3.00 | 0.10% |
| 2022-March | ₹3.00 | 0.33% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.50 | 0.79% |
| 2018-March | ₹1.20 | 0.33% |
| 2017-March | ₹1.50 | 0.25% |
Dr. Agrawals Eye Hospital Index Membership - Market Screener Classification
Screen DRAGARWQ by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Dr. Agrawals Eye Hospital Market Events Screener - Corporate Actions
Screen DRAGARWQ market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.50 /share | 6.35% | ||
| Dividend | ₹ 3.00 /share | 105.12% | ||
| Dividend | ₹ 3.00 /share | 46.51% | ||
| Annual General Meeting | NA | -7.76% | ||
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 3.00 /share | 2.42% |
| 2025-10-30 | 2025-10-30 | Quarterly Result Announcement | NA | -3.36% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.71% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 2.34% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -4.87% |
| 2024-11-08 | 2024-11-08 | Dividend | ₹ 2.50 /share | 0.26% |
| 2024-10-29 | 2024-10-29 | Quarterly Result Announcement | NA | -1.55% |
| 2024-08-26 | 2024-08-26 | Annual General Meeting | NA | 0.11% |
| 2024-08-19 | 2024-08-20 | Dividend | ₹ 2.50 /share | 14.07% |
| 2023-10-31 | 2023-10-31 | Dividend | ₹ 2.50 /share | -5.93% |
Dr. Agrawals Eye Hospital Competitors Screener - Peer Comparison
Screen DRAGARWQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Max Healthcare Institute | 103,308 | 75.17 | 7,184 | 28.65% | 1,076 | 38.86 |
| Apollo Hospitals | 102,001 | 59.14 | 21,994 | 14.76% | 1,505 | 46.86 |
| Fortis Healthcare | 69,109 | 65.35 | 7,850 | 13.25% | 809 | 49.90 |
| Narayana Hrudayalaya | 39,366 | 46.76 | 5,575 | 12.29% | 790 | 57.19 |
| Global Health | 32,677 | 57.06 | 3,771 | 12.59% | 481 | 51.45 |
| Aster DM Healthcare | 31,735 | 86.09 | 4,287 | 15.12% | 337 | 40.34 |
| Krishna Institute of Medical Sciences | 25,307 | 69.30 | 3,067 | 21.98% | 415 | 33.50 |
| Dr. Agarwal's Health Care | 15,850 | 109.02 | 1,757 | 27.64% | 110 | 47.42 |
| Kovai Medical Center Hospital | 13,955 | 27.37 | 600 | 11.69% | 58 | 34.31 |
| Rainbow Childrens Medicare | 13,416 | 52.38 | 1,567 | 17.46% | 244 | 41.00 |
Dr. Agrawals Eye Hospital Company Announcements - News Screener
Screen DRAGARWQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-31 | Closure of Trading Window | View |
| 2025-10-30 | Corporate Action-Board approves Dividend | View |
| 2025-10-30 | Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-30 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim Dividend | View |
| 2025-10-27 | Corporate Action - Fixes Record Date As November 07 2025 For The Purpose Of Interim Dividend If Declared By The Board | View |
| 2025-10-27 | Update on board meeting | View |
| 2025-10-22 | Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half-Year Ended September 30 2025 | View |
| 2025-10-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-26 | Closure of Trading Window | View |
| 2025-09-26 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-15 | Corrigendum To The Notice Of The 31St Annual General Meeting To Be Held On Wednesday September 24 2025 At 10 A.M. | View |
| 2025-09-03 | Newspaper Advertisement-31St Annual General Meeting And Information On E-Voting And Other Related Information | View |
| 2025-09-02 | Corporate Action-Record Date For Final Dividend- September 18 2025 | View |
| 2025-09-02 | Shareholders Meeting On September 24 2025 | View |
| 2025-09-02 | Reg. 34 (1) Annual Report. | View |
| 2025-08-27 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-08-27 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |